|
|
|
Volumn 5, Issue 11, 2004, Pages 1198-1204
|
|
IDN-6556 Idun Pharmaceuticals Inc
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 [2 [(2 TERT BUTYLPHENYLAMINOOXALYL)AMINO]PROPIONYLAMINO] 4 OXO 5 (2,3,5,6 TETRAFLUOROPHENOXY)PENTANOIC ACID;
ANTIINFLAMMATORY AGENT;
CASPASE 3;
CASPASE 7;
CASPASE INHIBITOR;
INTERFERON;
N [2 (1,1 DIMETHYLETHYL)PHENYL] 2 OXOGLYCYL N [1 (CARBOXYMETHYL) 2 OXO 3 (2,3,5,6 TETRAFLUOROPHENOXY)PROPYL]ALANINAMIDE;
PLACEBO;
PRALNACASAN;
UNCLASSIFIED DRUG;
VX 765;
ALCOHOL LIVER DISEASE;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
DRUG CLASSIFICATION;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HEADACHE;
HEART FAILURE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
INFECTIOUS HEPATITIS;
LEUKOCYTE DISORDER;
LIVER DISEASE;
LIVER TRANSPLANTATION;
NONHUMAN;
OSTEOARTHRITIS;
PAIN;
PHLEBITIS;
PSORIASIS;
RHEUMATOID ARTHRITIS;
STOMACH PAIN;
STRUCTURE ACTIVITY RELATION;
XEROSTOMIA;
ANIMALS;
CASPASES;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
HUMANS;
PENTANOIC ACIDS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 9144227580
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
